* InspireMD Inc NSPR.OQ reported a quarterly adjusted loss
of 53 cents per share for the quarter ended in September. The
lone analyst forecast for the quarter was for a loss of 82 cents
per share.
* Revenue rose 9.3% to $1.07 million from a year ago; analysts
expected $1.20 million.
* InspireMD Inc's reported EPS for the quarter was a loss of 53
cents.
* The mean earnings estimate of analysts had fallen by
about 30.2% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* InspireMD Inc shares had risen by 1.2% this quarter and
lost 18.8% so far this year.
* The company reported a quarterly loss of $4.07 million.
* Wall Street's median 12-month price target for InspireMD Inc
is $16.50
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated November 9 at 02:32 p.m.
All figures in US dollars unless otherwise stated